Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Targeted Mesenchymal Stem Cell Product
- Development stage
- Preclinical
- Lead developer
- Guangzhou Saijun Biotechnology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
The Targeted Mesenchymal Stem Cell Product is a second-generation cell therapy developed by Guangzhou Saijun Biotechnology (CellGenes). Positioned as a 'targeted' stem cell drug, it is engineered to enhance the natural homing capabilities of mesenchymal stem cells (MSCs) to specific tissues, organs, or sites of inflammation and injury. This targeting technology aims to overcome the limitations of conventional MSC therapies, such as low accumulation at the target site and rapid systemic clearance, thereby potentially increasing therapeutic efficacy and reducing the required dosage. While the company's first-generation product (SJ001) focuses on emergency rescue using bone marrow-derived MSCs, this targeted iteration is designed for more precise intervention in various pathological conditions.
- Other names
- 靶向性间充质干细胞产品全球首个靶向干细胞药物Targeted Mesenchymal Stem Cells
Beyond the preview
Go deeper on Targeted Mesenchymal Stem Cell Product.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Targeted Mesenchymal Stem Cell Product.